{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:08:39Z","timestamp":1792728519570,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.anl.2020.09.001","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T17:29:11Z","timestamp":1600104551000},"page":"353-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma"],"prefix":"10.1016","volume":"48","author":[{"given":"Yukiko","family":"Iino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Sekine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saori","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2020.09.001_bib0001","series-title":"Proceedings of the second extraordinary international symposium on recent advances in otitis media","first-page":"183","article-title":"Intractable otitis media in cases with bronchial asthma","author":"Tomioka","year":"1993"},{"key":"10.1016\/j.anl.2020.09.001_bib0002","series-title":"Cholesteatoma and mastoid surgery","first-page":"851","article-title":"Intractable otitis media in patients with bronchial asthma (eosinophilic otitis media)","author":"Tomioka","year":"1997"},{"key":"10.1016\/j.anl.2020.09.001_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0385-8146(01)00124-9","article-title":"Clinical characteristics of so-called eosinophilic otitis media","volume":"29","author":"Nagamine","year":"2002","journal-title":"Auris Nasus Larnyx"},{"key":"10.1016\/j.anl.2020.09.001_bib0004","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/MAO.0b013e318263d5b8","article-title":"Clinical efficacy of anti-IgE therapy for eosinophilic otitis media","volume":"33","author":"Iino","year":"2012","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2020.09.001_bib0005","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.anl.2018.07.011","article-title":"Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media","volume":"46","author":"Iino","year":"2019","journal-title":"Auris Nasus Larynx"},{"issue":"10086","key":"10.1016\/j.anl.2020.09.001_bib0006","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(17)31191-1","article-title":"Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomized, double-blinded, placebo-controlled, phase 3 trial","volume":"389","author":"Blauvelt","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2020.09.001_bib0007","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2147\/CE.S133661","article-title":"Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis","volume":"13","author":"Eshtiaghi","year":"2018","journal-title":"Core Evid"},{"key":"10.1016\/j.anl.2020.09.001_bib0008","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12325-018-0702-4","article-title":"Liberty Asthma QUEST: Phase 3 randomized, double-blind, placebo-controlled, parallel-group study to evaluate dupilumab efficacy\/safety in patients with uncontrolled, moderate-to-severe asthma","volume":"35","author":"Busse","year":"2018","journal-title":"Adv Ther"},{"issue":"378","key":"10.1016\/j.anl.2020.09.001_bib0009","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"28","author":"Castro","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2020.09.001_bib0010","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"issue":"10209","key":"10.1016\/j.anl.2020.09.001_bib0011","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LEIBERTY NP SINUS=24 and LIBERTY NP SINUS-52): results from two multicenter, randomized double-blind, placebo-controlled parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2020.09.001_bib0012","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.anl.2010.11.016","article-title":"Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease","volume":"38","author":"Iino","year":"2011","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2020.09.001_bib0013","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1081-1206(10)60967-2","article-title":"Effectiveness of instillation of triamcinolone acetonide into middle ear for eosinophilic otitis media associated with bronchial asthma","volume":"97","author":"Iino","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"Suppl","key":"10.1016\/j.anl.2020.09.001_bib0014","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0194-5998(97)70005-6","article-title":"Staging for rhinosinusitis","volume":"117","author":"Lund","year":"1997","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2020.09.001_bib0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.05.008","article-title":"The differential expression of IL4 and IL13 and its impact on type-2 immunity","volume":"75","author":"Bao","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.anl.2020.09.001_bib0016","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.cyto.2015.05.014","article-title":"IL-4 and IL-13 signaling in allergic airway disease","volume":"75","author":"Gour","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.anl.2020.09.001_bib0017","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cyto.2015.05.018","article-title":"Strategies targeting the IL-4\/IL-13 axes in disease","volume":"75","author":"May","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.anl.2020.09.001_bib0018","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1056\/NEJMoa021481","article-title":"Endogenous antimicrobial peptides and skin infections in atopic dermatitis","volume":"347","author":"Ong","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2020.09.001_bib0019","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/all.13685","article-title":"Dupilumab reduces local type 2 pro-inflammatory biomarkers in chronic rhinosinusitis with nasal polyposis","volume":"74","author":"Jonstam","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2020.09.001_bib0020","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1080\/0036554021000028117","article-title":"IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion","volume":"123","author":"Nonaka","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.anl.2020.09.001_bib0021","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1111\/j.1365-2222.2005.02330.x","article-title":"Eosinophil chemoattractant in middle ear of patients with eosinophilic otitis media","volume":"35","author":"Iino","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.anl.2020.09.001_bib0022","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1001\/archotol.132.10.1109","article-title":"Eustachian tube function in patients with eosinophilic otitis media","volume":"132","author":"Iino","year":"2006","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.anl.2020.09.001_bib0023","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1002\/cpdd.798","article-title":"Pharmacokinetics, pharmacodynamics safety and tolerability of dupilumab in healthy adult subjects","volume":"9","author":"Li","year":"2020","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.anl.2020.09.001_bib0024","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd3838","article-title":"Targeting eosinophils in allergy, inflammation and beyond","volume":"12","author":"Fulkerson","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.anl.2020.09.001_bib0025","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1111\/all.13814","article-title":"Periostin: an emerging biomarker for allergic diseases","volume":"74","author":"Izuhara","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.anl.2020.09.001_bib0026","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.anl.2014.09.003","article-title":"Differential expression of periostin in the nasal polyp may represent distinct histological features of chronic rhinosinusitis","volume":"42","author":"Shiono","year":"2015","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2020.09.001_bib0027","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2332\/allergolint.13-RAI-0673","article-title":"Expressions and roles of periostin in Otolaryngological diseases","volume":"63","author":"Ohta","year":"2014","journal-title":"Allergol Int"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620302480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814620302480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:37:29Z","timestamp":1759952249000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814620302480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0385814620302480"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2020.09.001","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2020.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}